BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 1698821)

  • 1. High level transcription of the glucocerebrosidase pseudogene in normal subjects and patients with Gaucher disease.
    Sorge J; Gross E; West C; Beutler E
    J Clin Invest; 1990 Oct; 86(4):1137-41. PubMed ID: 1698821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A glucocerebrosidase fusion gene in Gaucher disease. Implications for the molecular anatomy, pathogenesis, and diagnosis of this disorder.
    Zimran A; Sorge J; Gross E; Kubitz M; West C; Beutler E
    J Clin Invest; 1990 Jan; 85(1):219-22. PubMed ID: 2295698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel transcript from a pseudogene for human glucocerebrosidase in non-Gaucher disease cells.
    Imai K; Nakamura M; Yamada M; Asano A; Yokoyama S; Tsuji S; Ginns EI
    Gene; 1993 Dec; 136(1-2):365-8. PubMed ID: 8294033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 55-base pair deletion in certain patients with Gaucher disease complicates screening for common Gaucher alleles.
    Tayebi N; Stern H; Dymarskaia I; Herman J; Sidransky E
    Am J Med Genet; 1996 Dec; 66(3):316-9. PubMed ID: 8985494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new gene-pseudogene fusion allele due to a recombination in intron 2 of the glucocerebrosidase gene causes Gaucher disease.
    Cormand B; Díaz A; Grinberg D; Chabás A; Vilageliu L
    Blood Cells Mol Dis; 2000 Oct; 26(5):409-16. PubMed ID: 11112377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differentiation of the glucocerebrosidase gene from pseudogene by long-template PCR: implications for Gaucher disease.
    Tayebi N; Cushner S; Sidransky E
    Am J Hum Genet; 1996 Sep; 59(3):740-1. PubMed ID: 8751878
    [No Abstract]   [Full Text] [Related]  

  • 7. Erroneous assignment of Gaucher disease genotype as a consequence of a complete gene deletion.
    Beutler E; Gelbart T
    Hum Mutat; 1994; 4(3):212-6. PubMed ID: 7833951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gaucher disease and parkinsonism: a phenotypic and genotypic characterization.
    Tayebi N; Callahan M; Madike V; Stubblefield BK; Orvisky E; Krasnewich D; Fillano JJ; Sidransky E
    Mol Genet Metab; 2001 Aug; 73(4):313-21. PubMed ID: 11509013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucocerebrosidase pseudogene variation and Gaucher disease: Recognizing pseudogene tracts in GBA alleles.
    Martínez-Arias R; Comas D; Mateu E; Bertranpetit J
    Hum Mutat; 2001 Mar; 17(3):191-8. PubMed ID: 11241841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymorphisms in the glucocerebrosidase gene and pseudogene urge caution in clinical analysis of Gaucher disease allele c.1448T>C (L444P).
    Brown JT; Lahey C; Laosinchai-Wolf W; Hadd AG
    BMC Med Genet; 2006 Aug; 7():69. PubMed ID: 16887033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymorphisms in the human glucocerebrosidase gene.
    Beutler E; West C; Gelbart T
    Genomics; 1992 Apr; 12(4):795-800. PubMed ID: 1572652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two novel polymorphic sequences in the glucocerebrosidase gene region enhance mutational screening and founder effect studies of patients with Gaucher disease.
    Lau EK; Tayebi N; Ingraham LJ; Winfield SL; Koprivica V; Stone DL; Zimran A; Ginns EI; Sidransky E
    Hum Genet; 1999 Apr; 104(4):293-300. PubMed ID: 10369158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalent and rare mutations among Gaucher patients.
    Eyal N; Wilder S; Horowitz M
    Gene; 1990 Dec; 96(2):277-83. PubMed ID: 2269438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Type 2 Gaucher disease with hydrops fetalis in an Ashkenazi Jewish family resulting from a novel recombinant allele and a rare splice junction mutation in the glucocerebrosidase locus.
    Reissner K; Tayebi N; Stubblefield BK; Koprivica V; Blitzer M; Holleran W; Cowan T; Almashanu S; Maddalena A; Karson EM; Sidransky E
    Mol Genet Metab; 1998 Apr; 63(4):281-8. PubMed ID: 9635296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucocerebrosidase gene mutations in patients with type 2 Gaucher disease.
    Stone DL; Tayebi N; Orvisky E; Stubblefield B; Madike V; Sidransky E
    Hum Mutat; 2000; 15(2):181-8. PubMed ID: 10649495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular analysis of Gaucher disease in a Vietnamese-Czechoslovak patient with high residual glucocerebrosidase activity.
    Choy FY; Woo M; Der Kaloustian VM
    Am J Med Genet; 1991 Jun; 39(4):466-71. PubMed ID: 1877626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gaucher disease in Colombia: mutation identification and comparison to other Hispanic populations.
    Pomponio RJ; Cabrera-Salazar MA; Echeverri OY; Miller G; Barrera LA
    Mol Genet Metab; 2005 Dec; 86(4):466-72. PubMed ID: 16185907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simple PCR amplification of the entire glucocerebrosidase gene (GBA) coding region for diagnostic sequence analysis.
    Finckh U; Seeman P; von Widdern OC; Rolfs A
    DNA Seq; 1998; 8(6):349-56. PubMed ID: 10728820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gaucher disease: functional expression of the normal glucocerebrosidase and Gaucher T1366G and G1604A alleles in Baculovirus-transfected Spodoptera frugiperda cells.
    Choy FY; Wei C; Levin D
    Am J Med Genet; 1996 Oct; 65(3):184-9. PubMed ID: 9240741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of denaturing gradient gel electrophoresis to identify mutant sequences in the beta-glucocerebrosidase gene.
    Laubscher KH; Glew RH; Lee RE; Okinaka RT
    Hum Mutat; 1994; 3(4):411-5. PubMed ID: 8081401
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.